{"name": "CoLucid Pharmaceuticals",
 "permalink": "colucid-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/colucid-pharmaceuticals",
 "homepage_url": "http://www.colucid.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@colucid.com",
 "phone_number": "919-806-4304",
 "description": "",
 "created_at": "Wed Aug 31 03:37:02 UTC 2011",
 "updated_at": "Wed Aug 31 03:57:55 UTC 2011",
 "overview": "\u003Cp\u003ECoLucid Pharmaceuticals, Inc., a biotechnology company, focuses on therapies for central nervous system disorders. The company develops COL-144, a neurally acting anti-migraine agent, which is designed to treat migraine; and COL-204, a conjugated stigmine platform that produces novel chemical entities for therapy of sleep/wake disorders, chronic pain, Alzheimer\u0026#8217;s disease, and psychiatric disorders. CoLucid Pharmaceuticals was founded in 2005 and is based in Research Triangle Park, North Carolina.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       57],
      "assets/images/resized/0015/1961/151961v1-max-150x150.png"],
     [[210,
       81],
      "assets/images/resized/0015/1961/151961v1-max-250x250.png"],
     [[210,
       81],
      "assets/images/resized/0015/1961/151961v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO and Chairman",
    "person":
     {"first_name": "Artthur",
      "last_name": "M. Pappas",
      "permalink": "artthur-m-pappas",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0026/7047/267047v1-max-150x150.jpg"],
          [[200,
            200],
           "assets/images/resized/0026/7047/267047v1-max-250x250.jpg"],
          [[200,
            200],
           "assets/images/resized/0026/7047/267047v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Board of Director",
    "person":
     {"first_name": "Jesse",
      "last_name": "I. Treu",
      "permalink": "jesse-i-treu",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0026/4133/264133v1-max-150x150.jpg"],
          [[150,
            150],
           "assets/images/resized/0026/4133/264133v1-max-250x250.jpg"],
          [[150,
            150],
           "assets/images/resized/0026/4133/264133v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$7.5M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.prnewswire.com/news-releases/colucid-pharmaceuticals-raises-75-million-of-planned-95-million-128664483.html",
    "source_description": "CoLucid Pharmaceuticals Raises $7.5 Million of Planned $9.5 Million",
    "raised_amount": 7500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 8,
    "funded_day": 30,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Pappas Ventures",
         "permalink": "pappas-ventures",
         "image":
          {"available_sizes":
            [[[150,
               131],
              "assets/images/resized/0004/9245/49245v1-max-150x150.png"],
             [[164,
               144],
              "assets/images/resized/0004/9245/49245v1-max-250x250.png"],
             [[164,
               144],
              "assets/images/resized/0004/9245/49245v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Domain Associates",
         "permalink": "domain-associates",
         "image":
          {"available_sizes":
            [[[150,
               72],
              "assets/images/resized/0003/2807/32807v1-max-150x150.png"],
             [[250,
               121],
              "assets/images/resized/0003/2807/32807v1-max-250x250.png"],
             [[264,
               128],
              "assets/images/resized/0003/2807/32807v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Care Capital",
         "permalink": "care-capital",
         "image":
          {"available_sizes":
            [[[110,
               80],
              "assets/images/resized/0004/9581/49581v1-max-150x150.jpg"],
             [[110,
               80],
              "assets/images/resized/0004/9581/49581v1-max-250x250.jpg"],
             [[110,
               80],
              "assets/images/resized/0004/9581/49581v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Pearl Street Venture Funds",
         "permalink": "pearl-street-venture-funds",
         "image":
          {"available_sizes":
            [[[134,
               150],
              "assets/images/resized/0008/9105/89105v1-max-150x150.jpg"],
             [[202,
               225],
              "assets/images/resized/0008/9105/89105v1-max-250x250.jpg"],
             [[202,
               225],
              "assets/images/resized/0008/9105/89105v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Triathlon Medical Venture Partners",
         "permalink": "triathlon-medical-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               49],
              "assets/images/resized/0004/5663/45663v2-max-150x150.png"],
             [[200,
               66],
              "assets/images/resized/0004/5663/45663v2-max-250x250.png"],
             [[200,
               66],
              "assets/images/resized/0004/5663/45663v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}